The Framingham function overestimates the risk of ischemic heart disease in HIV-infected patients from Barcelona

被引:14
|
作者
Herrera, Sabina [1 ]
Guelar, Ana [1 ]
Sorli, Luisa [1 ]
Vila, Joan [2 ]
Molas, Ema [1 ]
Grau, Maria [2 ]
Marrugat, Jaume [2 ]
Esteve, Erika [1 ]
Gueerri-Fernandez, Roberto [1 ]
Montero, Milagro [1 ]
Knobel, Hernando [1 ]
机构
[1] Hosp Mar, Dept Infect Dis, Barcelona 08003, Spain
[2] IMIM Hosp Mar Med Res Inst, Cardiovasc Epidemiol & Genet, Barcelona, Spain
来源
HIV CLINICAL TRIALS | 2016年 / 17卷 / 04期
关键词
Cardiovascular risk; Framingham; HIV; REGICOR; CARDIOVASCULAR RISK; MYOCARDIAL-INFARCTION; ANTIRETROVIRAL THERAPY; EUROPEAN POPULATIONS; CORONARY-DISEASE; MORTALITY-RATES; DATA-COLLECTION; TASK-FORCE; SPAIN; TRENDS;
D O I
10.1080/15284336.2016.1177266
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Cardiovascular risk (CVR) assessment helps to identify patients at high CVR. The Framingham CVR score (FRS) is the most widely used methods but may overestimate risk in regions with low incidence of cardiovascular disease. The objective was to compare the 10-year performance of the original and the adapted REGICOR - Framingham CVR functions in HIV-infected individuals. Methods: We carried out a longitudinal study of HIV-infected patients with CVR evaluation in a hospital in Barcelona between 2003 and 2013. Statistics: Risk probability was calculated using the FRAMINGHAM function and REGICOR adaptation to the Spanish population, and individuals were categorized in three groups (low, 0 < 5%; moderate, 5-10%; and high, > 10%). For each risk group, the number of events over 10 years was calculated using the Kaplan-Meier method, and the expected number of events was calculated by multiplying the frequency of participants in the group by the mean of the probabilities from the risk function. We used the X-2 goodness-of-fit test to assess agreement between observed and expected. Results: Six hundred and forty-one patients were followed up for a median of 10.2 years, and 20 ischemic heart events (IHE) were observed. The mean (95% CI) number of IHEs per 1000 person-years was 3.7 (2.06-5.27). The estimates from the Framingham and REGICOR functions were 40 and 14 IHEs, respectively. The estimate from the original Framingham function differed significantly from the observed incidence (p < 0.001), whereas that from the REGICOR-adapted function did not (p = 0.15). In terms of the number of cardiovascular events (38 events observed), the REGICOR function significantly underestimated risk (p = 0.01), whereas the estimate from the Framingham function was similar to observed (p: 0.93). Conclusions: The FRS significantly overestimates risk of IHE events in our HIV-infected patients, while the REGICOR function is a better predictor of these events. In terms of cardiovascular events, the REGICOR function significantly underestimates risk, whereas the FRS is a better estimator. We recommend using CVR scales and adjusting them to the origin of the population being studied.
引用
收藏
页码:131 / 139
页数:9
相关论文
共 50 条
  • [1] Control of cardiovascular risk factors in HIV-infected patients with ischemic heart disease
    Vallecillo Sanchez, Gabriel
    Vilaplana Marz, Laia
    Esteve Palou, Erika
    Knobel Freud, Hernando
    [J]. MEDICINA CLINICA, 2012, 139 (09): : 412 - 413
  • [2] Framingham Equation Model Overestimates Risk of Ischemic Heart Disease in Korean Men and Women
    Ahn, Kyung A.
    Yun, Ji Eun
    Cho, Eo Rin
    Nam, Chung Mo
    Jang, Yangsu
    Jee, Sun Ha
    [J]. EPIDEMIOLOGY AND HEALTH, 2006, 28 (02): : 162 - 170
  • [3] Coronary heart disease risk assessment in HIV-infected patients: a comparison of Framingham, PROCAM and SCORE risk assessment functions
    Moreira Guimaraes, M. M.
    Greco, D. Bartolomeu
    Ingles Garces, A. H.
    de Oliveira, A. R., Jr.
    Foscolo, R. Bastos
    de Campos Machado, L. J.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (06) : 739 - 745
  • [4] Coronary Heart Disease in HIV-Infected Patients
    Arzhakova, Maria A.
    Shekhovtsova, Tatyana A.
    Duplyakov, Dmitry, V
    [J]. RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2019, 15 (06) : 900 - 905
  • [5] Risk of cardiovascular disease in HIV-infected patients
    Das, Satyajit
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (03) : 386 - 389
  • [6] Prediction of coronary heart disease risk in HIV-infected patients with fat redistribution
    Hadigan, C
    Meigs, JB
    Wilson, PWF
    D'Agostino, RB
    Davis, B
    Basgoz, N
    Sax, PE
    Grinspoon, S
    [J]. CLINICAL INFECTIOUS DISEASES, 2003, 36 (07) : 909 - 916
  • [7] Prevalence of Ischemic Heart Disease and Management of Coronary Risk in Daily Clinical Practice: Results from a Mediterranean Cohort of HIV-Infected Patients
    Echeverria, Patricia
    Domingo, Pere
    Llibre, Josep-Maria
    Gutierrez, Mar
    Mateo, Gracia
    Puig, Jordi
    Bonjoch, Anna
    Alvarez, Nuria Perez
    Sirera, Guillem
    Clotet, Bonaventura
    Negredo, Eugenia
    [J]. BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [8] Coronary heart disease in HIV-infected patients.
    Glesby M.J.
    [J]. Current HIV/AIDS Reports, 2005, 2 (2) : 68 - 73
  • [9] Framingham risk function overestimates risk of coronary heart disease in men and women from Germany -: results from the MONICA Augsburg and the PROCAM cohorts
    Hense, HW
    Schulte, H
    Löwel, H
    Assmann, G
    Keil, U
    [J]. EUROPEAN HEART JOURNAL, 2003, 24 (10) : 937 - 945
  • [10] Risk of Coronary Heart Disease among HIV-Infected Patients: A Multicenter Study in Brazil
    Fuchs, Sandra C.
    Alencastro, Paulo R.
    Ikeda, Maria Leticia R.
    Barcellos, Nemora T.
    Wolff, Fernando H.
    Brandao, Ajacio B. M.
    Ximenes, Ricardo A. A.
    Miranda-Filho, Demorito de B.
    Lacerda, Heloisa Ramos
    de Albuquerque, Maria de Fatima P. M.
    Montarroyos, Ulisses Ramos
    Nery, Max W.
    Turchi, Marilia D.
    [J]. SCIENTIFIC WORLD JOURNAL, 2013,